Medical Xpress January 9, 2025
Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help doctors make more informed treatment decisions for people with stage 1 lung cancer, potentially reducing the risk of the cancer returning or spreading.
In research published in Nature Cancer, the team tested ORACLE in 158 people with lung cancer as part of the TRACERx study. They found that ORACLE could better predict patient survival than currently used clinical standards like tumor stage.
ORACLE was developed in 2019 to overcome the lack of biological markers in lung cancer, which can indicate to...
Today's Sponsors
Today's Sponsor